Navigation Links
Progress in Osteoporosis re-launched with new design, now invites commentary
Date:6/12/2012

The International Osteoporosis Foundation (IOF) has published the first issue of the newly revised Progress in Osteoporosis (PIO). Available online on the IOF website at http://www.iofbonehealth.org/sub-hubs/progress-in-osteoporosis, the monthly journal is edited by renowned bone expert and author Professor Ego Seeman of the University of Melbourne.

The free online journal has been revised in terms of design and content, placing increased focus on critical review. A new option invites commentary by readers.

Professor Seeman commented on the journal's revised scope and intention to provide deeper understanding and critical thinking in the bone field. "The purpose of PIO, which began as Advances in Osteoporosis 19 years ago, was to give readers without easy access to research summaries of the most important recent literature. We now inhabit a virtual world. Information is instantaneously accessible to all at the tap of a keyboard. Understanding is not."

The new PIO reflects this development: Its new format continues to provide critical evaluation of the important literature, but now also promotes discussion by inviting assessment of the quality of information published.

IOF COO Judy Stenmark stated, "This is surely the most unique online scientific forum in the bone field. The Editor is renowned for his outspoken critique and I am certain readers will enjoy the opportunity to participate through online commentary."

To access PIO, readers must register for FREE IOF MEMBERSHIP on the International Osteoporosis Foundation website at http://www.iofbonehealth.org


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Progress of arachidonic acid biosynthesis in microorganisms
2. Stem cell research paves way for progress on dealing with Fragile X retardation
3. Research!America says house funding levels for FY13 could undermine medical progress
4. Europe meets to discuss progress in energy research and development
5. Major osteoporosis meeting opens in São Paulo
6. Second Middle East & Africa Osteoporosis Meeting to take place in Jordan
7. Study: Men who do load-bearing exercise in early 20s may be shielded from osteoporosis
8. Scientists have discovered genes that increase the risk of osteoporosis and fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016 According to a new market research report "Emotion ... Expression, Voice Recognition), Service, Application Area, End User, And Region - Global Forecast ... USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a ... Reading ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)...  Genprex, Inc. a biopharmaceutical company focused on ... announced that it has retained ICR Healthcare, a ... and advisory firm, to develop and implement an ... investor relations, public relations and digital communications to ... Genprex and its lead candidate Oncoprex, which is ...
(Date:12/7/2016)... Regen BioPharma Inc. (OTCQB: RGBPP) In a recent ... team of scientists in Guangzhou, China ... of NR2F6 in patients with early cervical cancer correlates with ... cancer tissue as well as in the normal tissue surrounding ... study and the first that I am aware of that ...
Breaking Biology Technology: